Responses
Poster Presentations
Spondyloarthritis - treatment
THU0354 Disease worsening and safety in patients switching from originator infliximab to biosimilar infliximab (CT-P13) in the randomized nor-switch-study: explorative analysis in SPA patients
Compose a Response to This Article
Other responses
No responses have been published for this article.